ALASKA - “A nationwide cLAimS data laKe for sleep Apnea"
A large-scale analysis of the French national healthcare database (SNDS*), which explored the patient profiles and PAP adherence of almost half-a-million sleep apnoea patients during their first three years of PAP therapy.
ALASKA study outcomes:
ALASKA showed that it’s important to consider patient phenotyping and personalised care when developing integrated sleep apnoea management strategies.
Our infographic highlights the key findings.
ALASKA study results:
Chances of survival increased by 39% and the risk of developing heart failure and hypertension reduced for patients continuing PAP treatment throughout the first year: ALASKA’s second publication followed 176,014 PAP patients in the French healthcare system database over 3 years.
For more, download our infographic.
Obstructive sleep apnoea research
Improved compliance, greater efficiencies, higher quality of care – here is some of the latest research that provides evidence of these results.
Central sleep apnoea research
Switching patients with persistent or emergent CSA from CPAP to ASV may improve compliance. Learn more about the findings from this big data study.
SERVE-HF has become a key study in its field, contributing significantly to ASV clinical practice. Learn more about the study design, results and implications for clinical practice.